Phillippe A. Cassier

Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors

Sarina A. Piha‐Paul, Christine L. Hann, Christopher A. French et al. · JNCI Cancer Spectrum · 2019 · 207 citations · Full text

Medicine, Oncology, Pharmacology +17

Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors

Lecia V. Sequist, Phillippe A. Cassier, Andréa Varga et al. · Cancer Research · 2014 · 76 citations

Medicine, Oncology, Pharmacology +16

Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors

Tae Won Kim, Philippe L. Bédard, Patricia LoRusso et al. · JAMA Oncology · 2023 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors

Lecia V. Sequist, Phillippe A. Cassier, Andréa Varga et al. · Kölner Universitäts PublikationsServer (Universität zu Köln) · 2014 · 37 citations

Medicine, Oncology, Pharmacology +8